Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-26-051139
Filing Date
2026-05-04
Accepted
2026-05-04 06:57:17
Documents
87
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0288344-10k_apimeds.htm   iXBRL 10-K 1135200
2 DESCRIPTION OF SECURITIES ea028834401ex4-1.htm EX-4.1 27501
3 INSIDER TRADING POLICY ea028834401ex19-1.htm EX-19.1 64642
4 SUBSIDIARIES OF THE REGISTRANT ea028834401ex21-1.htm EX-21.1 1596
5 CERTIFICATION ea028834401ex31-1.htm EX-31.1 9559
6 CERTIFICATION ea028834401ex31-2.htm EX-31.2 9511
7 CERTIFICATION ea028834401ex32-1.htm EX-32.1 3803
8 CERTIFICATION ea028834401ex32-2.htm EX-32.2 3810
9 EXECUTIVE COMPENSATION RECOVERY POLICY ea028834401ex97-1.htm EX-97.1 17066
10 GRAPHIC ea028834401_img1.jpg GRAPHIC 296527
11 GRAPHIC ea028834401_img2.jpg GRAPHIC 34648
  Complete submission text file 0001213900-26-051139.txt   6878411

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE apus-20251231.xsd EX-101.SCH 57951
13 XBRL CALCULATION FILE apus-20251231_cal.xml EX-101.CAL 61777
14 XBRL DEFINITION FILE apus-20251231_def.xml EX-101.DEF 255316
15 XBRL LABEL FILE apus-20251231_lab.xml EX-101.LAB 503539
16 XBRL PRESENTATION FILE apus-20251231_pre.xml EX-101.PRE 288493
91 EXTRACTED XBRL INSTANCE DOCUMENT ea0288344-10k_apimeds_htm.xml XML 514985
Mailing Address 100 MATAWAN RD SUITE 325 MATAWAN NJ 07747
Business Address 100 MATAWAN RD SUITE 325 MATAWAN NJ 07747 848-201-5010
Apimeds Pharmaceuticals US, Inc. (Filer) CIK: 0001894525 (see all company filings)

EIN.: 851099700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-42545 | Film No.: 26934573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)